HDL therapy for the sub-acute treatment of patients with acute coronary syndromes

被引：0

作者：

Newton, R. S. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Exper Therapeut, Ann Arbor, MI USA

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期

关键词：

D O I：

10.1016/S1567-5688(06)80024-3

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：11 / 11

页数：1

共 3 条

[1] HDL therapy for the acute treatment of atherosclerosis [J].

Newton, RS ;

Krause, BR .

ATHEROSCLEROSIS SUPPLEMENTS, 2002, 3 (04) :31-38

[2] Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano [J].

Nicholls, SJ ;

Tuzcu, EM ;

Sipahi, I ;

Schoenhagen, P ;

Crowe, T ;

Kapadia, S ;

Nissen, SE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (05) :992-997

[3] Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial [J].

Nissen, SE ;

Tsunoda, T ;

Tuzcu, EM ;

Schoenhagen, P ;

Cooper, CJ ;

Yasin, M ;

Eaton, GM ;

Lauer, MA ;

Sheldon, WS ;

Grines, CL ;

Halpern, S ;

Crowe, T ;

Blankenship, JC ;

Kerensky, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17) :2292-2300

← 1 →